4/A: Omada Health Insider Trades Correction Filing

Omada Health's Chief Accounting Officer, Craig Gracey, filed a Form 4/A to correct an earlier filing, reporting an omitted stock option exercise and sale transaction.

Summary

• This filing is an amendment (Form 4/A) to a previously filed Form 4 by Craig Gracey, Chief Accounting Officer of Omada Health, Inc.
• The amendment corrects an inadvertent omission of a stock option exercise transaction from the original filing dated June 16, 2026.
• The omitted exercise was part of a same-day exercise-and-sale transaction, with the sale having been timely reported.
• Due to the omission, the reported beneficial ownership following the sale was understated.
• The filing corrects the beneficial ownership amount in Box 5 of Table I.
• A total of 6,250 shares were acquired via option exercise at a price of $6.57 per share.
• A total of 6,894 shares were sold at a weighted average price of $17.4243 per share, with individual trade prices ranging from $17.04 to $17.71.
• The option exercise was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
• The stock option vests over four years from September 9, 2024, with 25% vesting on the first anniversary and monthly vesting thereafter.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It's a procedural correction of an insider transaction, not indicative of company performance, but the need for amendment suggests a minor administrative oversight.

Positives

• The company has a Chief Accounting Officer actively managing their equity holdings.
• The use of a Rule 10b5-1 trading plan indicates proactive and planned equity management by the executive.
• The correction was made promptly, ensuring accurate reporting of beneficial ownership.
• The sale of shares occurred at a price significantly higher than the option exercise price, indicating a profitable transaction for the executive.

Negatives

• An omission in the original filing led to an understatement of beneficial ownership, requiring an amendment.
• The executive sold shares, which could be interpreted negatively by the market, although it was part of a pre-planned transaction.

Risks

• Potential for market misinterpretation of the share sale, despite it being part of a 10b5-1 plan.
• The need for an amendment suggests a potential lapse in internal controls or diligence in reporting, though this is a minor correction.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding the company's future performance. It is a transactional filing related to insider equity.

Management Comments

• The transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for tracking insider transactions. The use of a 10b5-1 plan by Omada Health's Chief Accounting Officer is a common practice for executives to diversify their holdings or manage liquidity in a pre-determined manner, mitigating concerns about insider trading.

Stakeholder Impact

• Shareholders: The correction ensures accurate reporting of beneficial ownership, maintaining transparency. The sale itself, being part of a pre-planned 10b5-1, is unlikely to cause significant concern if the market understands the plan's purpose.

Next Steps

• The executive's 10b5-1 plan will continue to execute as scheduled.
• The company's investor relations may field inquiries regarding the corrected filing.

Key Dates

Keywords

Form 4/A, Omada Health, Insider Trading, Stock Options, Beneficial Ownership, Rule 10b5-1, SEC Filing, Executive Compensation, Equity Management, Craig Gracey